ACR Appropriateness Criteria ® Prostate Cancer—Pretreatment Detection, Surveillance, and Staging-Reference-Cited by-同舟云学术

ACR Appropriateness Criteria ® Prostate Cancer—Pretreatment Detection, Surveillance, and Staging

Published:2017-05 Issue:5 Volume:14 Page:S245-S257
ISSN:1546-1440
Container-title:Journal of the American College of Radiology
language:en
Short-container-title:Journal of the American College of Radiology

Author:

Coakley Fergus V.,Oto Aytekin,Alexander Lauren F.,Allen Brian C.,Davis Brian J.,Froemming Adam T.,Fulgham Pat F.,Hosseinzadeh Keyanoosh,Porter Christopher,Sahni V. Anik,Schuster David M.,Showalter Timothy N.,Venkatesan Aradhana M.,Verma Sadhna,Wang Carolyn L.,Remer Erick M.,Eberhardt Steven C.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference94 articles.

1. Impact of biochemical recurrence in prostate cancer among US veterans;Uchio;Arch Intern Med,2010

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. The economic burden of prostate cancer;Roehrborn;BJU Int,2011

4. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens;Evans;Am J Surg Pathol,2008

5. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911);van der Kwast;Virchows Arch,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted biopsy of the prostate;Abdominal Radiology;2024-07-08

2. Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review;Journal of Clinical Epidemiology;2024-05

3. Prostate Cancer Local Staging with Magnetic Resonance Imaging;Radiologic Clinics of North America;2024-01

4. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis;European Urology Oncology;2023-12

5. Mise au point et stratégies thérapeutiques dans le cancer de la prostate avancé et métastatique;Médecine Nucléaire;2023-11